ARS Pharmaceuticals, Inc. (SPRY)
2.96
-0.40
(-11.90%)
USD |
NASDAQ |
Nov 20, 16:00
2.95
-0.01
(-0.34%)
After-Hours: 20:00
ARS Pharmaceuticals Shareholders Equity (Quarterly) : -11.96M for Sept. 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -11.96M |
| June 30, 2026 | 12.51M |
| March 31, 2026 | 61.31M |
| December 31, 2025 | 114.26M |
| September 30, 2025 | 147.66M |
| June 30, 2025 | 192.32M |
| March 31, 2025 | 228.97M |
| December 31, 2024 | 256.80M |
| September 30, 2024 | 200.98M |
| June 30, 2024 | 215.24M |
| March 31, 2024 | 223.87M |
| December 31, 2023 | 230.76M |
| September 30, 2023 | 237.28M |
| June 30, 2023 | 248.55M |
| Date | Value |
|---|---|
| March 31, 2023 | 261.16M |
| December 31, 2022 | 272.89M |
| September 30, 2022 | 267.07M |
| June 30, 2022 | 278.79M |
| March 31, 2022 | 293.23M |
| December 31, 2021 | 44.77M |
| September 30, 2021 | 332.13M |
| June 30, 2021 | 349.65M |
| March 31, 2021 | 368.55M |
| December 31, 2020 | 382.88M |
| September 30, 2020 | 138.32M |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | -5.603M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Capricor Therapeutics, Inc. | 209.76M |
| Sionna Therapeutics, Inc. | 240.52M |
| Ardelyx, Inc. | 164.05M |
| Compass Therapeutics, Inc. | 142.57M |
| ACADIA Pharmaceuticals, Inc. | 1.387B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 251.48M |
| Total Liabilities (Quarterly) | 263.44M |
| Debt to Equity Ratio | -10.19 |
| Current Ratio | 3.251 |
| Net Debt Paydown Yield | -5.56% |